The AI in life science analytics market is experiencing significant growth. This growth is driven by advancements in big data, AI, and analytics, which are crucial for improving efficiency and accuracy in life sciences applications.
AI’s ability to enhance data analysis is revolutionizing healthcare by enabling faster, more precise, and personalized patient care. Additionally, trends indicate a rising adoption of AI technologies among for-profit life sciences companies, highlighting their importance in optimizing research and operational processes in the sector.
| 1.0 |
AI & Data Analytics in Life Sciences |
| 1.10 |
Drug Discovery | Understanding the role of AI |
| 1.20 |
AI | Pharma’s “AlphaGo Moment” |
| 1.30 |
Application of AI for Advanced R&D |
| 1.40 |
Comparison of Top-50 Leading AI* for Drug Discovery Companies |
| 1.50 |
Key Players in AI Drug Discovery |
| 1.60 |
AP Companies & Investors | Regional Landscape |
| 1.70 |
End-to-end Drug Development Companies by Therapeutic Focus |
| 1.80 |
Investments in AI in Drug Development |
| 1.90 |
Top AI in Pharma Investments |
| 1.10 |
AI & Pharma collaboration in Q1 2023 |
| 1.11 |
Challenges in Discovery Process |
| 1.12 |
Solutions | Used Cases |
| 1.13 |
Impact of AI on Time and Cost of Drug Discovery |
| 1.14 |
Introduction to AI-first & Investments in the Market |
| 1.15 |
Pipeline and Therapeutic Area Focus of ‘AI-first’ Biotech |
| 1.16 |
Obstacles Preventing AI Adoption in Drug Discovery |
| 1.17 |
Collaborations Involving AI for Drug Discovery |
| 1.18 |
Pharma AI Deals of 2023 |
| 1.19 |
AI-enabled Drug Discovery | Case Study |
| 2.0 |
Data Analytics in Life Science |
| 2.10 |
Introduction |
| 2.20 |
Market Overview |
| 2.30 |
Applications |
| 2.40 |
Market Drivers |
| 2.50 |
Use Cases |
| 2.60 |
Advantages |
| 2.70 |
Challenges of Life Science Data |
| 2.80 |
Key Players | Geographical Presence |
| 2.90 |
How Data and Analytics are Transforming Patient Pathways |
| 2.10 |
How Data and Analytics accelerate Drug Development and Discovery |
| 3.0 |
Key Takeaways |
| 3.10 |
Forward Looking Statements |
Global mRNA-Based Therapeutics Market 1 × $350.00
